ArticleMolecular therapy oncolytics2023

Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers.

Thanyavi Chinsuwan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.